1. Home
  2. CRTO vs FTRE Comparison

CRTO vs FTRE Comparison

Compare CRTO & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Criteo S.A.

CRTO

Criteo S.A.

HOLD

Current Price

$16.41

Market Cap

780.6M

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$15.48

Market Cap

829.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRTO
FTRE
Founded
2005
1996
Country
France
United States
Employees
3649
N/A
Industry
Advertising
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
780.6M
829.3M
IPO Year
2013
2023

Fundamental Metrics

Financial Performance
Metric
CRTO
FTRE
Price
$16.41
$15.48
Analyst Decision
Strong Buy
Buy
Analyst Count
10
9
Target Price
$34.00
$14.06
AVG Volume (30 Days)
235.3K
1.4M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
38.95
N/A
EPS
0.15
N/A
Revenue
$2,296,692,000.00
$2,723,400,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$5.54
$3.09
P/E Ratio
$5.92
N/A
Revenue Growth
27.65
1.00
52 Week Low
$15.58
$3.97
52 Week High
$28.91
$18.67

Technical Indicators

Market Signals
Indicator
CRTO
FTRE
Relative Strength Index (RSI) 37.25 81.17
Support Level N/A $8.85
Resistance Level $20.10 $18.26
Average True Range (ATR) 0.90 0.85
MACD -0.31 0.61
Stochastic Oscillator 18.63 90.00

Price Performance

Historical Comparison
CRTO
FTRE

About CRTO Criteo S.A.

Criteo SA is an ad-tech company in the digital advertising market. Its technology allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. It has two reportable segments: Retail Media and Performance Media. Retail Media: This segment encompasses revenue generated from brands, agencies, and retailers for the purchase and sale of retail media digital advertising inventory and audiences, and services. Performance Media: This segment encompasses targeting capabilities and supply and AdTech services. The majority of its revenues is generated from the performance media segment.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: